The placebo effect is real brain chemistry, not just imagination

Give someone an inert pill they believe is medicine and, under the right conditions, their body answers for real. The placebo effect isn’t merely “thinking positive”: it produces measurable changes in pain, heart rate, hormones and brain activity, driven by expectation and learned association.

The clearest evidence is chemical. Placebo pain relief recruits the brain’s own endogenous opioids — and naloxone, a drug that blocks opioid receptors, can switch that relief off, proving real neurochemistry is at work. In Parkinson’s patients, a placebo “drug” triggered measurable dopamine release on PET scans. Conditioning matters too: pair a sugar pill with a real medicine enough times, and the pill alone can start producing the drug’s response.

The flip side is the nocebo effect, from the Latin for “I shall harm”: when people expect a treatment to hurt them, they report genuine side effects and worse symptoms. Expectation cuts both ways.

Even open-label placebos — pills patients are openly told contain no active drug — produced significant relief in trials for irritable bowel syndrome.

The ritual itself seems to carry weight, which is why the effect reaches all the way into the operating room. In one landmark trial of patients with knee osteoarthritis, those given sham (placebo) surgery — anesthesia and skin incisions, but no actual procedure inside the joint — reported no more pain and no less function, even two years later, than those who got the real arthroscopic operation. The more elaborate the ritual, it seems, the stronger the response.

The effect has its limits: it eases self-reported symptoms like pain, nausea and fatigue rather than shrinking a tumor or lowering cholesterol, and its size varies enormously between people. But its reality is no longer in doubt — which is exactly why every new drug must beat a placebo to earn approval.